Generalised anxiety disorder (GAD) and panic disorder are two of the most common mental health conditions seen in adults, and they often show up first in general practice rather than in a psychologist's office. They are not the same experience. GAD involves worry that is persistent and pervasive, spreading across many areas of life without a clear trigger. Panic disorder involves sudden, intense episodes of fear accompanied by physical symptoms.
There is no evidence to support screening every patient for these conditions, but clinicians are encouraged to consider assessment when someone describes ongoing, wide-ranging worry, or presents with physical symptoms that have no medical explanation. Validated tools, including the GAD-7 and the Patient Health Questionnaire for panic disorder, can help with diagnosis. Anxiety disorders frequently occur alongside substance use problems, and these need to be addressed at the same time, not treated as separate issues.
Cognitive behavioural therapy and certain antidepressants, including SSRIs and SNRIs, are effective treatments for both conditions. Benzodiazepines are not recommended as a first-line option or for long-term use, given the risk of adverse effects, dependence, and higher mortality. There is no clear evidence for a specific prevention strategy, though exercise may offer some benefit.
If worry or panic has started shaping your daily decisions, it is worth speaking with a psychologist about what might help.
Generalised anxiety disorder and panic disorder are among the most common mental health conditions clinicians encounter in primary care, meaning the everyday GP setting rather than specialist mental health services. A recent clinical review drew together current evidence on how both are recognised and treated in adults.
What the conditions actually involve
GAD is characterised by recurrent, pervasive worry that keeps returning across many areas of life and does not resolve on its own. Panic disorder involves sudden, intense episodes of fear, often accompanied by somatic symptoms, meaning physical rather than purely emotional symptoms, which are not explained by an underlying medical condition. The review advises clinicians to consider assessing for these conditions when someone presents with that kind of pervasive worry, or with unexplained physical symptoms, rather than assuming the cause is purely medical.
The review also states there is not yet enough evidence to support universal screening, meaning testing everyone regardless of symptoms. Assessment is instead recommended in a targeted way, based on how a person presents.
How they are assessed
Two validated screening tools are highlighted: the GAD-7, a short questionnaire measuring generalised anxiety symptoms, and the Patient Health Questionnaire for Panic Disorder. Validated means these tools have been tested against clinical diagnoses to confirm they reliably capture what they are meant to measure. They assist diagnosis and track severity. They do not replace a full clinical assessment.
One further clinical point carries weight. Anxiety disorders frequently occur alongside substance use disorders, and the review is clear that where this happens, both need treating at the same time rather than one after the other.
What the evidence supports for treatment
Cognitive behavioural therapy, a structured and skills-based therapy that helps people identify and change unhelpful thought patterns and behaviours, is identified as effective for both conditions. On the medication side the review points to antidepressants, specifically selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors. Both work by altering levels of particular neurotransmitters, the chemical messengers in the brain associated with the regulation of mood and anxiety.
Benzodiazepines, a class of fast-acting sedative medication, are explicitly not recommended as a first-line treatment or for long-term use. The review cites adverse reactions, risk of dependence and higher mortality as the reasons for that caution.
What remains unknown
The review notes there is currently no consistent evidence supporting any specific strategy for preventing GAD or panic disorder from developing, though exercise is mentioned as potentially beneficial. This is also a clinical review summarising existing evidence rather than a new experiment, so its strength depends on the quality of the studies it draws together.
If worry or panic symptoms have begun shaping your daily choices, or if you have found yourself leaning on something simply to get through the day, speaking with a psychologist or GP is a reasonable step.